scholarly journals Diagnosis-specific sick leave as a risk marker for disability pension in a Swedish population

2007 ◽  
Vol 61 (10) ◽  
pp. 915-920 ◽  
Author(s):  
M. Kivimaki ◽  
J. E Ferrie ◽  
J. Hagberg ◽  
J. Head ◽  
H. Westerlund ◽  
...  
BMJ Open ◽  
2020 ◽  
Vol 10 (9) ◽  
pp. e035996
Author(s):  
Katharina Büsch ◽  
Fredrik Hansson ◽  
Michelle Holton ◽  
Martin Lagging ◽  
Johan Westin ◽  
...  

ObjectiveThe objective of this study was to evaluate sick leave and disability pension in patients with chronic hepatitis C virus (HCV) infection as compared with a matched general population cohort.DesignRetrospective register study.SettingNationwide in Sweden.ParticipantsThis register-based study used the Swedish National Patient Register to identify working-age patients with HCV in 2012 (n=32 021) who were diagnosed between 1999 and 2007 (n=19 362). Sick leave and disability pension data were retrieved from Statistics Sweden (1994–2012), with up to five matched individuals from the general population.Primary and secondary outcome measuresThe primary outcome was workdays lost due to sick leave episodes (>14 days) and disability pension overall. The secondary outcome was workdays lost per subgroup of patients with chronic HCV.ResultsIn 2012, 14% of the HCV patients had ≥1 registered sick leave episode compared with 10% in the matched comparator cohort. For disability pension benefits, results were 30% versus 8%, respectively. Overall, in 2012, 57% of patients with HCV did not have any registered workdays lost, whereas 30% were absent ≥360 days compared with 83% and 9% in the matched cohort, respectively. The mean total number of annual workdays lost in 2012 was 126 days in the HCV patient cohort compared with 40 days in the matched general population comparator cohort. Annual days lost increased from a mean of 86 days 5 years before diagnosis to 136 days during the year of diagnosis.ConclusionsThese results show that Swedish HCV patients used more sick days and have a higher frequency of disability pension compared with a comparator cohort from the general Swedish population. Whether earlier diagnosis of HCV and treatment might impact work absence in Sweden warrants further investigation.


2011 ◽  
Vol 53 (6) ◽  
pp. 633-640 ◽  
Author(s):  
Jaana Kuoppala ◽  
Anne Lamminpää ◽  
Irma Väänänen-Tomppo ◽  
Katariina Hinkka

2017 ◽  
Vol 69 (2) ◽  
pp. 226-233 ◽  
Author(s):  
Jenny Hubertsson ◽  
Aleksandra Turkiewicz ◽  
Ingemar F. Petersson ◽  
Martin Englund

2020 ◽  
pp. 140349482094654
Author(s):  
Roy A. Nielsen ◽  
Tove I. Midtsundstad

Aims: This study aimed to investigate whether introducing workplace health-promotion interventions targeting employees with health problems or reduced work ability affected overall sick leave and disability risk. Methods: The study population comprised data from an establishment survey from 2010 identifying who had introduced workplace health promotion (the intervention) linked to register data on all employees and their sickness absence and disability pension uptake from 2000 through 2010. Results: Interventions had moderate effects due to varying efficacy in different parts of the labour market. Intervention success was more likely among white-collar workers (e.g. in public administration) compared to blue-collar workers (e.g. in manufacturing), probably due to variations in both organisational and technological constraints. Effects were small among men and moderate among older workers, particularly among women. Overall, disability risk reduction was accompanied by an increase in sickness absence. Sometimes, sickness absence increased in groups with no change in disability risk, suggesting that presenteeism in one group may increase absenteeism in other groups. Conclusions: Introducing workplace health-promotion interventions may prolong work careers in some labour-market segments. Financial incentives for Norwegian establishments to continue offering workplace health-promotion interventions may be improved, given the current financial model for disability pension and sickness benefits.


2016 ◽  
Vol 22 (14) ◽  
pp. 1859-1866 ◽  
Author(s):  
Erik Landfeldt ◽  
Anna Castelo-Branco ◽  
Axel Svedbom ◽  
Emil Löfroth ◽  
Andrius Kavaliunas ◽  
...  

Background: Multiple sclerosis (MS) is associated with considerable morbidity and serious disability, but little is known of the long-term impact of the disease on work ability. Objectives: To assess sick leave (short-term absence) and disability pension (long-term absence) before and after diagnosis of MS. Methods: Patients with MS in Sweden were identified in a nationwide disease-specific register and matched with general population controls. Sick leave and disability pension were measured before and after index (i.e. the MS diagnosis date). Results: The final sample comprised 6092 patients and 60,345 controls (mean age 39 years; 70% female). The mean annual prevalence of sick leave ranged from 12% the first year after index to 23% after 11 years among patients and from 13% to 13% among controls. Corresponding estimates for disability pension were 12% and 55% for patients and 7% and 9% for controls. Significant differences in sick leave were observed up to 15 years before index and 3 years for disability pension. Conclusion: Patients with MS in Sweden have elevated levels of sick leave and disability pension up to 15 years before disease diagnosis. Our results highlight the burden of disease on affected patients and society and underscore the substantial unmet medical need.


2014 ◽  
Vol 8 (11) ◽  
pp. 1362-1377 ◽  
Author(s):  
Katharina Büsch ◽  
Simone A. da Silva ◽  
Michelle Holton ◽  
Fabiana M. Rabacow ◽  
Hamed Khalili ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document